Ropes & Gray represented Arbor Biotechnologies in the transaction. Arbor Biotechnologies announced its $73.9 million Series C financing to support the advancement of its novel gene…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
